• Tesla's stock is slightly up after falling sharply the day before on reports that the automaker will slow production at its Shanghai, China, plant in January.
  • Southwest Airlines drew the wrath of the U.S. government on Tuesday, as the winter storm that hit the United States highlighted major dysfunctions within the group, which was responsible for 90% of all flight cancellations by U.S. airlines.
  • In China, demand for Pfizer's Covid-19 antiviral pill explodes.
  • Boeing wins contract for 40 737-8 jets from BOC Aviation.
  • Nio reduces its delivery outlook due to production issues.
  • FDA explores regulations for cannabis-derived products, which doesn't sit well with industry players like Canopy Growth and Tilray Brands.
  • Ryanair, Wizz Air and EasyJet are being investigated by Italian antitrust over prices for flights in Sicily.
  • Mastercard says Christmas shopping was up 8% in the US.
  • AstraZeneca gets regulatory approval for Calquence, a blood cancer treatment, in Japan.
  • Gilead Sciences buys rights to cancer treatment from Jounce Therapeutics for $67 million.
  • Swiss, a unit of Lufthansa, is grounding its passenger flights to China until further notice.
  • Infineon Technologies is ready to spend several billion euros in its search for acquisitions, according to its CEO.
  • Equinor completes upgrades to the Njord field in the Norwegian Sea.
  • Pierer Mobility raises its revenue forecast for 2022.
  • Kuehne+Nagel International wins a logistics contract from Shimano of Japan.
  • Skanska AB wins a $120 million contract to improve a national highway interchange in the United States.
  • Otovo Asa expands into Belgium, the Netherlands and Switzerland.
  • Sonae proposes to acquire the remaining stake in Sonaecom.
  • Gruppo MutuiOnline Spa announces that Akela Srl has acquired 5600 ordinary shares of the group.
  • Webuild Spa has acquired 39,294 of its own ordinary shares.